Premium
QUANTITATIVE EXPRESSION OF HLA CLASS I MOLECULES IN ACUTE NON‐LYMPHOBLASTIC LEUKAEMIA CELLS
Author(s) -
D'Alfonso S.,
Savoia P.,
Pitti G.,
Peruccio D.,
Pozzi C.,
Crepaldi T.,
Falda M.,
Ficara F.,
Resegotti L.,
Richiardi P. Momigliano
Publication year - 1993
Publication title -
international journal of immunogenetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.41
H-Index - 47
eISSN - 1744-313X
pISSN - 1744-3121
DOI - 10.1111/j.1744-313x.1993.tb00107.x
Subject(s) - human leukocyte antigen , immunofluorescence , beta 2 microglobulin , microbiology and biotechnology , biology , messenger rna , immunology , hla dr , phenotype , western blot , real time polymerase chain reaction , antibody , gene , antigen , genetics
SUMMARY The present study concerns a panel of 33 acute non lymphoblastic leukaemia (ANLL) patients, previously typed for HLA‐A,B serological specificities and including samples with a normal HLA‐A,B phenotype (3,4 detected specificities) as well as samples with missing and extra specificities. Samples were analysed at the protein and/or RNA level in order to verify whether the observed typing anomalies were due to a modified quantitative expression of class I molecules. The number of HLA‐A.B assigned specificities correlated significantly with the cell surface class I expression detected by indirect immunofluorescence using the monomorphic anti‐class I MoAb W6/32 (Spearman rank correlation test, P < 0.01) and with the amount of class I Heavy Chain (HC, P < 0.05) and beta‐2‐microglobulin (β2m, P < 0.05) evaluated by Western blot in whole cell extracts. The RNA analysis suggested a HC‐β2m coordinated down regulation at the mRNA level in a patient with no assigned HLA‐A,B specificities. Another patient with no detectable HLA‐A,B specificities showed a low expression selectively of the β2m protein. The results reported here demonstrate a heterogenous quantitative HLA class I expression in ANLL blasts, analogous to results reported for solid tumours.